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Purpose: Oxidative stress has been suggested to play a role
as a common mediator of apoptosis and kidney damage in
diabetes. However, it is uncertain whether the apoptosis occurs
in the kidney during the course of diabetes. We investigated
the occurrence of apoptosis in the diabetic rat kidney, the role
of oxidative stress and the effect of an antioxidant on
apoptosis in the diabetic rat kidney. Materials and Methods:
Otsuka-Long-Evans-Tokushima-Fatty rats, an animal model
for type 2 diabetes, were randomized into a non-treated
diabetic (n = 8) and a vitamin C-treated group (n = 8). Long-
Evans Tokushima Otsuka rats (n = 8 ) were used as a control.
Results: Apoptosis was present in the epithelial cells of the
proximal tubules in diabetic rats. The number of apoptotic
cells, albuminuria, proteinuria, glomerular and tubulointerstitial
sclerosis, and renal malondialdehyde were significantly
decreased in vitamin C-treated diabetic rats when compared to
the untreated diabetic rats. The decreased slit pore density
(number of slit pores per underlying glomerular basement
membrane length) as assessed by electron microscopy was also
significantly restored by treatment with vitamin C without
significantly affecting plasma glucose in diabetic rats.
Conclusion: By blocking these pathophysiologic processes, a
blockade of oxidative stress by vitamin C might become a
useful adjunct to albuminuria and renal sclerosis in diabetic
nephropathy.
Key Words: Apoptosis, diabetic nephropathy, oxidative stress,
slit pore, vitamin C
INTRODUCTION
Diabetic nephropathy is a leading cause of end-
stage renal disease. It is characterized functionally
by proteinuria and albuminuria and pathologically
by glomerular hypertrophy, mesangial expansion
and tubulointerstitial fibrosis; these findings are
closely related to the loss of renal function. Accu-
mulating research suggests that oxidative stress
plays a key role in the pathogenesis of diabetic
nephropathy. In addition, antioxidant administration
has been reported to have potentially beneficial
effects in the human kidney and experimental
diabetes.
1-4
Oxidative stress has been suggested to play a
role as a common mediator in apoptosis
5,6 and in
particular diabetic nephropathy, a state in which
oxidative stress increased.
1 Recent reports provide
evidence that high ambient glucose can promote
apoptosis in vitro, suggesting potential cellular
damage as a result of hyperglycemia in diabetes in
vitro.
7 However, it is uncertain whether apoptosis
occurs in the kidney during the course of diabetes.
Vitamin C plays a central role in the antioxidant
defense system
8 and apotosis.
9 In the general
absence of metal ion-catalyzed reactions, vitamin
C is qualitatively the single most important plasma
antioxidant. Thus, vitamin C is the antioxidant of
choice in antioxidant experiments in vitro.
10 However,
its efficacy in clinical use remains to be confirmed.
Therefore we investigated the occurrence of
apoptosis in the diabetic kidney and evaluated the
effects of the antioxidant vitamin C on apoptosis,
oxidative stress, and the functional and pathologic
changes in the kidney of diabetic rats.
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MATERIALS AND METHODS
Experimental animals
The Otsuka Long-Evans Tokushima Fatty rats,
an animal model of human type 2 diabetes, and
Long-Evans Tokushima Otsuka rats (n = 8) as a
control strain were supplied by Otsuka Pharma-
ceutical, Tokushima, Japan. The characteristic
features of OLETF rats are known as a gradual
and late onset of hyperglycemia, a chronic course
of disease, mild obesity, and a typical renal
pathologic finding similar to that of humans.
11
Male diabetic rats weighing 280 - 320g at 12 weeks
of age were randomized into an untreated
diabetic group (n = 8) and a vitamin C-treated
diabetic group (n = 8). The research protocol was
approved by the Yonsei University Wonju College
of Medicine’s animal ethical committee. Treatment
was started at 16 weeks of age. The untreated
diabetic group was given untreated drinking
water. The vitamin C-treated diabetic group was
given 10 g/L vitamin C (Ascorbic acid ) in their
drinking water. Diabetic rats receiving vitamin C
supplementation consumed an average of 0.9g/kg
of body weight/day. Throughout the study all
rats were maintained on standard rat chow (EP2 ,
Sam Yang, Seoul, Korea). Body weights and
plasma glucose concentrations were determined at
8-week intervals. All rats were killed at 32 weeks
of age. Blood was collected from the abdominal
aorta, and serum was frozen to determine protein,
albumin and creatinine excretion. The kidneys
were perfused so as to be free of blood with PBS,
and a portion was fixed in 4% paraformaldehyde
for pathologic evaluation. A second portion was
quick-frozen in liquid nitrogen to measure
malondialdehyde (MDA).
Measurement of urinary protein and albumin
Twenty-four-hour urine samples were obtained
from animals in metabolic cages with access to
drinking water only at 8-week intervals. Urinary
total protein excretion was measured by the
quantitative 3% sulfosalycylic acid technique.
12
Urinary albumin excretion was measured by a
quantitative reaction with bromocresol green.
13 All
samples were assayed in triplicate and a mean
value was calculated for each rat.
Measurement of MDA in the kidney
One hundred milligrams of kidney was placed
in 1 mL of 10 mM PBS (pH 7.0) containing 50 M μ
butylated hydroxytoluene and homogenized with
10 strokes of a rotary homogenizer driven at 20
rev/min. The suspension was centrifuged at
10,000g for 10 min and the supernatant used to
determine MDA and protein. MDA was deter-
mined as described earlier
14 using thiobarbituric
acid as a standard and was prepared at con-
centrations in the range of the 0.2 to 2.5 M/L. μ
Supernatant or the standard (250 L) was added μ
to 250 L of 10% trichloroacetic acid and placed in μ
a boiling water bath for 2 min, after which 500 L μ
of 0.67% thiobarbituric acid was added and the
tubes were again incubated in the bath for 10 min.
The tubes were cooled and centrifuged at 10,000g
for 3 min, and the supernatant was read at 535 nm
using a Gilford spectrophotometer. The amount of
MDA formed was determined by spectrofluo-
rometry (SPF-500C, SLM Instruments) at an
emission wavelength of 553 nm, then calculated
using a tetraethoxypropane standard curve.
Renal histology
Random sections (3 m thick) of the renal cortex μ
were stained with periodic acid-Schiff (PAS). The
surface areas of 100 glomeruli were measured
with the Image-Pro (Version 1.2; Media Cyber-
netics, USA) software program on PAS stained
tissue section and glomerular volume (VG) was
calculated according to the method of Weibel and
Gomez.
15 VG=Area
1.5 × 1.38/1.01 where 1.38 re-
presents the shape coefficient, and 1.01 represents
the size distribution coefficient. The mesangial
matrix fraction was determined by the presence of
PAS positive material present in the mesangial
region, where researchers made sure to exclude
cellular elements. Regarding the glomerular
histopathologic changes, mesangial lesions were
scored semiquantitatively by mesangial expansion
and mesangial sclerosis. The scoring was performed
by a blinded observer. Mesangial expansion was
graded on a seven point scale: 0, normal; 1, mild
segmental mesangial expansion; 2, mild diffuseVitamin C and Diabetic Nephropathy
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mesangial expansion; 3, moderate diffuse
mesangial expansion; 4, severe diffuse mesangial
expansion; 5, segmental mesangial sclerosis; and
6, diffuse mesangial sclerosis.
16 Interstitial fibrosis
was scored semiquantitatively by a blinded
observer who examined cortical tubulointerstitial
fields on PAS-stained renal biopsies under a × 100
magnified field. At minimum, 30 fields were
assessed in each biopsy. The following semiquan-
titative scores were used: 0 normal interstitum
and tubules; 1, mild fibrosis with minimal
interstitial thickening between the tubules; 2,
modest fibrosis with moderate interstitial
thickening between the tubules; 3, severe fibrosis
with severe interstitial thickening between the
tuules.
17
TUNEL staining
Intranucleosomal DNA fragmentation was
labeled in situ using an apoptosis detection system
(DAKO, Baar, Switzerland) or the In Situ Cell
Death Detection Kit (Roche, Basel, Switzerland).
The formalin-fixed tissues were processed for
paraffin embedding, and 4 m-thick sections were μ
cut and mounted on slides. After deparaffini-
zation and rehydration, sections were digested
with proteinase K and treated according to the
protocol provided with the kit. Residues of
digoxigenin-nucleotide were catalytically added to
the 3’-OH ends of DNA by terminal deoxy-
nucleotidyl transferase (TdT). Sections were then
reacted with anti-digoxigenin antibody conjugated
with peroxidase as a reporter enzyme. Diamino-
benzidine for the apoptosis detection system or
NBT/BCIP (Roche, Basel, Switzerland) for the In
Situ Cell Death Detection Kit was used as the
chromogenic substrate for peroxidase, producing
a brown or deep blue reaction product that
marked the nuclei of apoptotic cells. Apoptosis
positive cells were counted in 6 consecutive inter-
stitial fields under the microscope (× 200) and
expressed as the mean number of positive stained
cells in the interstitial field.
Ultrastructural examination
A separate portion of the kidney was also
prepared for electron microscopy. Cubes were
obtained from the renal cortex and these sections
were fixed in 3% glutaraldehyde in 0.1M caco-
dylate buffer solution (pH 7.4) and postfixed in 1%
osmium tetraoxide in the same buffer at 4 . They
were then dehydrated in a graded series of
ethanol, passed through OY-1 (n-butyl glycidyl
ether) and finally embedded in epoxyresin. Ul-
trathin sections were stained with uranyl acetate
and lead citrate and were examined under a JEM
1200 EXII electron microscope (JEOL, Tokyo,
Japan). Glomerular basement membrane (GBM)
thickness was measured by the orthogonal inter-
cept method in electron photomicrographs. On
each glomerulus, 50 measurements were per-
formed. Electron micrographs of glomeruli were
taken with a magnification of × 10,000 without any
bias. The slit pore density was represented as the
number of slit pores per millimeter length of GBM
according to published methods.
18 The numbers of
slit pores between the podocyte foot processes on
the GBM were counted, and the slit pore density
was determined by dividing the number of slit
pores by the length of GBM measured.
Statistical analysis
Data are expressed as means ± SD. The signi-
ficance of differences was determined by ANOVA
followed by the Fisher’s multiple comparison test,
using SPSS win software.
RESULTS
Effects of vitamin C on the clinical data of diabetic
rats
As summarized in Tables 1 and 2, diabetic rats
gained body weight continuously compared with
the control rats. The mean weight was significantly
higher in diabetic rats than in control rats during
the study. Blood glucose concentrations were also
significantly higher in the diabetic rats. The absolute
mean kidney weight and kidney weight, expressed
as a function of body weight of diabetic rats were
significantly higher than that of control rats.
Vitamin C treatment did not affect blood
glucose concentration, absolute kidney weight, or
kidney weight expressed as a function of bodyEun Young Lee, et al.
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weight in diabetic rats. Although the mean weight
was slightly lower in vitamin C-treated diabetic
rats when compared with the untreated diabetic
rats at 24 weeks of age, there were no statistically
significant differences between the two groups at
other times.
Effects of vitamin C on proteinuria, albuminuria,
and renal MDA of diabetic rats
The administration of vitamin C for 16 weeks
significantly ameliorated proteinuria and albu-
minuria in diabetic rats, although proteinuria in
vitamin C-treated diabetic rats remained statisti-
cally higher than in the untreated diabetic rats
(Fig. 1).
Vitamin C treatment also significantly suppressed
renal MDA in diabetic rats without significantly
affecting blood glucose (Fig. 2).
Table 1. The Changes in Body Weights and Blood Glucose Concentrations over Time
Age of rats 16 wks 24 wks 32 wks
Body weight (g)
D 504 ± 28* 558 ± 38* 581 ± 44*
D + VC 493 ± 25* 511 ± 12*, 559 ± 33*
C 413 ± 24 454 ± 24 473 ± 31
Blood glucose (mg/dL)
D 138 ± 12* 133 ± 33* 384 ± 76*
D + VC 134 ± 12* 132 ± 16* 390 ± 54*
C 115 ± 16 119 ± 10 148 ± 51
D, untreated diabetic rats; D + VC, diabetic rats treated with vitamin C; C, non-diabetic control rats.
Values are presented as mean ± SD.
*p < 0.001 compared with C, p< 0.05 compared with D.
Table 2. Kidney Weight/Body Weight, Glomerular Area and Glomerular Volume in 32 Weeks of Age
D D + VC C
Kidney weight (g) 1.84 ± 0.06* 2.00 ± 0.21* 1.27 ± 0.08
Kidney weight/100g body weight 0.33 ± 0.02* 0.34 ± 0.03* 0.26 ± 0.01
Glomerular volume (× 10
4μ
3) 3.74 ± 0.47* 3.56 ± 0.49* 2.94 ± 0.32
GBM thickness (nm) 258.65 ± 72.48 248.25 ± 52.11 228.92 ± 24.90
D, untreated diabetic rats; D + VC, diabetic rats treated with vitamin C; C, non-diabetic control rats.
Values are preseted as mean ± SD.
*p < 0.001 compared with C.
Fig. 1. Effects of vitamin C on urinary protein and albumin
excretion in diabetic rats. Values are means ± SD. D,
diabetic rats; D + VC, diabetic rats treated with vitamin C;
C, non-diabetic control rats. *p < 0.001 compared with C, p
< 0.001 compared with D, p < 0.05 compared with D.Vitamin C and Diabetic Nephropathy
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Effects of vitamin C on renal histology of diabetic
rats
The mean glomerular volume of diabetic rats
was significantly higher than that of control rats.
Also the mean thickness of the GBM in diabetic
rats appeared to be higher than that of control
rats, but this difference did not reach statistical
significance (Table 2).
Semiquantitative analyses for mesangial and
tubulointerstitial lesions from different experi-
mental groups are summarized in Table 3. Glo-
merular expansion or sclerosis was significantly
increased in diabetic rats when compared with
control rats. Tubulointerstitial fibrosis was also
markedly increased in diabetic rats compared
with control rats. Vitamin C treatment effectively
inhibited diabetes-associated glomerular and tu-
bulointerstitial lesions.
Effects of vitamin C on slit pore density in
diabetic rats
The slit pore density (number of slit pores per
underlying GBM length) as assessed by electron
microscopy was decreased more in diabetic rats
than control rats (Fig. 3). But this change was
Fig. 2. Effect of vitamin C on renal MDA in diabetic rats.
Values are means ± SD. Values are means ± SD. D,
diabetic rats; D + VC, diabetic rats treated with vitamin
C; C, non-diabetic control rats. *p < 0.001 compared with
C, p < 0.001 compared with D.
Fig. 3. Effect of vitamin C on slit pore density in diabetic
rats. The slit pore density was expressed as the number of
slit pores between podocyte foot processes per millimeter
length of glomerular basement membrane by electron
microscopy. Representative electron photomicrographs
show examples of slit pores (arrows), which are more
prevalent in the diabetic rats. D, diabetic rats (A); D + VC,
diabetic rats treated with vitamin C (B); C, non-diabetic
control rats(C). Magnification, × 40,000. **p < 0.05 compared
with C, p < 0.01 compared with D.
A B C
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significantly restored by treatment with vitamin C
(Fig. 3), associated with amelioration of albumi-
nuria and proteinuria (Fig. 1).
Effects of vitamin C on apoptosis in diabetic rats
Apoptosis occured in the tubular epithelial
cells of proximal tubules in normal and diabetic
rats. However, there were no apoptotic cells in
the glomeruli in normal and diabetic rats (Fig. 4).
The number of apoptotic cells was significantly
decreased in vitamin C-treated diabetic rats
when compared to the untreated diabetic rats
(Fig. 5).
Fig. 4. Apoptosis in diabetic glomeruli. Intranucleosomal DNA fragmentation was labeled using the In Situ Cell Death
Detection Kit after 16 weeks of vitamin C treatment, as described in Materials and Methods. D, diabetic rats (A); C,
non-diabetic control rats (B). Magnification, × 400.
A B
Fig. 5. Effects of vitamin C on apoptosis in diabetic rats.
Intranucleosomal DNA fragmentation was labeled using
the Apoptosis detection system after 16 weeks of vitamin
C treatment, as described in Materials and Methods. D,
diabetic rats (A); D + VC, diabetic rats treated with
vitamin C (B). Magnification, ×100. Apoptosis positive
cells were counted in sixconsecutive interstitial fields
under the microscope and expressed as the mean
numbers of positive cells of the interstitial field (C).
Values are means ± SD. D, diabetic rats; D + VC, diabetic
rats treated with vitamin C. *p < 0.05 compared with D.
A B
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DISCUSSION
The present study demonstrates that vitamin C
treatment, at a dose that reduces renal MDA
accumulation, significantly ameliorates the pro-
gression of proteinuria and albuminuria. Vitamin
C also decreases slit pore density, apoptosis of
proximal tubular epithelial cells, degrees of glo-
merular injury, and tubulointerstitial damage in
diabetic rats without significantly affecting plasma
glucose.
Oxidative stress has been suggested to play an
important role in the pathogenesis of diabetic
nephropathy. Diabetic nephropathy is a state in
which oxidative stress increases and antioxidant
status is reduced, as has been documented.
1 Lipid
peroxidation increases in the kidney of diabetic
animals; this might be due to decreases in
antioxidant vitamins and enzymes. Glomerular
O
2-production was increased in untreated diabetic
rats compared with control rats.
19 The renal MDA
level, an index of oxidative stress, was increased
in the type 2 diabetic rat model
20 and the results
of present study are similar to those of prior
reports on studies of a type 1 streptozotocin-
induced diabetic rat model.
Recent reports provide evidence that high
ambient glucose can promote apoptosis, suggest-
ing potential cellular damage by hyperglycemia in
diabetes.
7,11 Hyperglycemia can trigger apoptosis
in renal cells in vitro.
7,21 High ambient glucose can
induce DNA fragmentation
22 and stimulate ex-
pression of apoptosis-regulatory genes
23 in renal
proximal tubular epithelial cells. In addition, apo-
ptosis was documented in renal tubular epithelial
cells; this may contribute to atrophy of the tubular
epithelium and tubulointerstitial fibrosis in
diabetic nephropathy. Diabetic nephropathy is
characterized by an early period of renal growth
with glomerular and tubular cell hypertrophy, but
this is followed by progressive glomerulosclerosis
and tubulointerstitial fibrosis, associated with loss
of renal tissue. We studied whether apoptotic cell
death occurs in diabetic nephropathy. We observed
that apoptotic cells were selectively present in the
epithelial cells of the proximal tubules. There were
no apoptotic cells in the glomeruli of diabetic rats
in this study. These findings are compatible with
the conclusion that apoptosis was present, either
in epithelial cells of the proximal or distal tubules,
in endothelial cells or interstitial cells. In addition,
no apoptosis was detected in human glomeruli
cells. The present study, along with other
investigations, provides evidence for the presence
of apoptosis in the human diabetic kidney; this
suggests a role for apoptosis in the gradual loss
of renal masses.
24
Oxidative stress is produced as a result of
diabetic conditions and possibly causes a variety
of tissue damage in patients with diabetes.
Increased oxidative stress in the diabetic kidney
may induce apoptosis, which may contribute to
the development of diabetic nephropathy.
25,26 The
decrease in antioxidant defense, such as vitamin
C, was also observed in patients with diabetic
nephropathy.
27 Diabetic nephropathy is charac-
terized by mesangial expansion as well as glo-
merular and tubulointerstitial fibrosis. Thus, cell
loss via apoptosis could be an important source
for glomerular and tubulointerstitial sclerosis in
diabetic nephropathy.
The effects of several antioxidants administered
at the onset of experimental diabetes have been
reported to prevent diabetic renal injury.
28,29
Antioxidant therapy may be beneficial in prevent-
ing the development of diabetic nephropathy.
Antioxidants might inhibit the development of
diabetic nephropathy by suppressing apoptosis.
The number of apoptotic cells was significantly
decreased in vitamin C-treated diabetic rats when
compared with untreated diabetic rats in this
study. Vitamin C plays a central role in the
antioxidant defense system. Vitamin C has been
shown to protect all classes of lipids from oxi-
dation under a number of relevant types of
oxidant stress, while other non-enzymatic antio-
xidants such as vitamin A, vitamin E, glutathione,
bilirubin, and urate merely lower the rate of
oxidation or act in a more restricted, local
environment.
30 The uncharged form of vitamin C,
dehydroascorbate, enters cells via a glucose trans-
porter and is then converted back to ascorbate
within these cells. Because dehydroascorbate and
glucose compete for glucose transporters, the
presence of hyperglycemia would work to exclude
vitamin C from the cell and results in a decreased
antioxidant capacity in some cell types that are
dehydroascorbate-dependent such as renal tu-Eun Young Lee, et al.
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bular epithelial cells. In diabetes, vitamin C
exclusion from tubular epithelial cells, through
competition of glucose and dehydroascorbate for
a common transport mechanism, will deprive the
cells of antioxidant ability and could lead to
reactive oxygen species accumulation.
8 Dietary
vitamins C and E with moderate exercise can
strengthen the antioxidant defense system through
the reduction of the reactive oxygen species and
blood glucose levels.
19 Treatment with vitamin C
and desferrioxamine significantly decreased
glomerular O
2- production.
19 Both vitamin C and
vitamin E decreased lipid peroxidation and
augmented the activities of antioxidant enzymes
studied in diabetic rat kidneys as well as reduced
urinary albumin excretion, decreased kidney
weight and glomerular basement membrane
thickness. These results indicate the potential
utility of antioxidant vitamins in protecting against
the development of diabetic nephropathy.
20
Several other antioxidants such as taurine and other
peroxynitrite scavengers attenuate hyperglycemia-
induced apoptosis in renal tubular cells by
inhibiting oxidative stress.
7,21
Podocytes play an important role in the main-
tenance of normal glomerular permselectivity.
Podocyte injury may lead to abnormal glomerular
permeability and to structural alterations of GBM
integrity, thereby leading to albuminuria and
proteinuria. Further podocyte damage may finally
result in glomerulosclerosis. Podocyte detachment
is seen in a wide variety of glomerular diseases
including metabolic or immunological glomerular
injury, such as diabetic nephropathy.
31 Recent
evidence shows that in early diabetes, the
podocyte suffers injury, dies, separates from the
GBM and leaves areas of the GBM denuded or the
podocytes, that are over-stretched, broaden their
foot processes and try to cover the space.
32 This
stud revealed the slit pore density was noticeably
reduced in the diabetic rats and was ameliorated
by the blockade of oxidative stress.
In this study, the levels of urinary protein,
albumin excretion, and renal MDA in vitamin
C-treated diabetic rats is significantly lower than
that of the untreated diabetic rats, but still
statistically higher than the control rats. Urinary
albumin excretion in our diabetic rats is similar to
those reported in a previous study.
18 Vitamin C
may prove to be a new therapeutic agent for
treating diabetic nephropathy. Vitamin C treat-
ment suppressed apoptosis in renal proximal
tubular epithelial cells without changing the blood
glucose levels, supporting the hypothesis that
apoptosis induced by oxidative stress causes
reduction of renal function in chronic hyper-
glycemia. Vitamin C treatment also decreased the
amounts of proteinuria and albuminuria. Our
results suggest that vitamin C treatment can exert
beneficial effects in diabetes patients, preserving
in vivo renal function and structure. Our findings
also support the potential usefulness of antio-
xidants in the treatment of diabetic nephropathy
and further implicate oxidative stress in renal
tubular cells apoptosis in diabetes.
33 However,
because our study is an animal study, these
findings must be confirmed after further study,
such as clinical trial, on human subjects.
In conclusion, treatment with vitamin C signi-
ficantly suppressed the progression of renal injury
in diabetic rats.
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